Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Migalastat awarded FDA fast track designation for Fabry disease

Sep. 20, 2017

Boehringer Ingelheim discovers SSAO inhibitors

Sep. 20, 2017

Board recommends continuation of MGL-3196 studies

Sep. 20, 2017

Phase II study of PBI-4050 in Alstrom syndrome shows beneficial clinical effects

Sep. 20, 2017

Daratumumab given U.S. orphan status for light-chain amyloidosis

Sep. 18, 2017

Intarcia Therapeutics reports topline results from study of switch from liraglutide to ITCA-650

Sep. 18, 2017

Roche describes novel cathepsin S inhibitors

Sep. 18, 2017

MEDI-4166 shows safety in type 2 diabetes subjects

Sep. 15, 2017

Zafgen begins phase II study of ZGN-1061 in type 2 diabetes

Sep. 14, 2017

Canalia launched in Japan for type 2 diabetes

Sep. 12, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...